The global blood bags market reached a value of US$ 256 Million in 2020. Looking forward, IMARC Group expects the market to exhibit moderate growth during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
A blood bag is used for the transfer, collection, storage, and transfusion of blood and its components, including platelets, plasma, and cryoprecipitate. It is generally manufactured from bio-compatible PVC materials and is integrated with collection tubes, needles, needle covers, and clamps. Blood bags are mostly available in the form of Citrate Phosphate Dextrose Adenine (CPDA) blood bags, Saline Adenine Glucose Mannitol (SAGM) blood bags, and transfer bags. Based on various transfusion types, they can be further classified into single, double, triple, and quadruple blood collection bags. These bags are widely adopted across surgery centers, trauma centers, emergency units, ambulatory facilities, intensive care units, etc.
The global blood bags market is primarily driven by the rising incidences of fatal accidents along with the wide presence of trauma centers across the world. According to estimates by the World Health Organization, nearly 1.4 million people die each year because of road traffic crashes. Moreover, the high prevalence of several blood-related medical ailments, such as anemia, hemophilia, myeloma, leukemia, etc., is also driving the demand for blood transfusion. Numerous invasive surgical procedures in the field of cardiology, neurology, orthopedics, oncology, etc., are further catalyzing this market for blood bag. Moreover, the rising investments in healthcare infrastructure development are also propelling the establishment of blood banks, medical research laboratories, and diagnostic centers. The introduction of several blood donation programs by various government bodies and non-profit organizations is also augmenting the market for blood bags.
IMARC Group provides an analysis of the key trends in each sub-segment of the global blood bags market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, product type, application, end user, material and capacity.
Breakup by Product Type:
Breakup by Application:
Breakup by End User:
Breakup by Material:
Breakup by Capacity:
Breakup by Region:
The competitive landscape of the industry has also been examined with some of the key players being Advacare Pharma, BL Life Sciences Private Limited, Demophorius Healthcare Ltd, Fresenius SE & Co. KGaA, Grifols S.A., Haemonetics Corporation, HLL Lifecare Limited, Innvol, JMS Co.Ltd., Kawasumi Laboratories, Inc., Maco Pharma International GmbH, Mitra Industries Pvt. Ltd., Neomedic Limited, Poly Medicure Ltd., Span Healthcare Private Limited, Suru International Private Ltd., Teleflex Incorporated, Terumo Corporation, The Metrix Company Ltd. and Troge Medical GmbH.
The global blood bags market size was valued at US$ 256 Million in 2020.
According to the estimates by IMARC Group, the global blood bags market is expected to exhibit moderate growth during 2021 to 2026.
The increasing demand for sterile biomedical devices for the transportation and transfusion of blood and its components due to the high prevalence of blood-related medical ailments, represents one of the key drivers for the global blood bags market.
The introduction of several blood donation programs by numerous government bodies and non-profit organizations represents one of the key industry trends in the global blood bags market.
Sudden outbreak of the COVID-19 pandemic had led to a rise in the demand for blood bags for transportation and transfusion of blood plasma for treating coronavirus infected patients.
On the basis of the application, the market has been bifurcated into collection blood bags and transfer blood bags. Currently, collection blood bags hold the majority of the total market share.
Based on the end user, the market has been segmented into hospitals, clinics, ambulatory surgical centers, blood banks, and others. Among these, hospitals represent the largest segment.
On the basis of the material, the market has been bifurcated into polyvinyl chloride blood bag, polyethylene terephthalate blood bag, and others. Among these, polyvinyl chloride bags hold the largest market share.
Region-wise, the market has been classified into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America, where Asia Pacific dominates the global market.
The key companies in the global blood bags market are AdvaCare Pharma, BL Life Sciences Private Limited, Demophorius Healthcare Ltd, Fresenius SE & Co. KGaA, Grifols S.A., Haemonetics Corporation, HLL Lifecare Limited, Innvol, JMS Co.Ltd., Kawasumi Laboratories, Inc., Maco Pharma International GmbH, Mitra Industries Pvt. Ltd., Neomedic Limited, Poly Medicure Ltd., Span Healthcare Private Limited, Suru International Private Ltd., Teleflex Incorporated, Terumo Corporation, The Metrix Company Ltd. and Troge Medical GmbH.
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at